Research progress of nanomaterial drug delivery in tumor targeted therapy

Cancer is one of the most lethal diseases in human society, and its incidence is gradually increasing. However, the current tumor treatment often meets the problem of poor efficacy and big side effects. The unique physical and chemical properties of nanomaterials can target the delivery of drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peng, Ye, Guihua, Xie, Guofeng, Lv, Jie, Zeng, Xianhai, Jiang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405625/
https://www.ncbi.nlm.nih.gov/pubmed/37555076
http://dx.doi.org/10.3389/fbioe.2023.1240529
_version_ 1785085572956553216
author Zhang, Peng
Ye, Guihua
Xie, Guofeng
Lv, Jie
Zeng, Xianhai
Jiang, Wei
author_facet Zhang, Peng
Ye, Guihua
Xie, Guofeng
Lv, Jie
Zeng, Xianhai
Jiang, Wei
author_sort Zhang, Peng
collection PubMed
description Cancer is one of the most lethal diseases in human society, and its incidence is gradually increasing. However, the current tumor treatment often meets the problem of poor efficacy and big side effects. The unique physical and chemical properties of nanomaterials can target the delivery of drugs to tumors, which can improve the therapeutic effect while reducing the damage of drugs to normal cells. This makes nanomaterials become a hot topic in the field of biomedicine. This review summarizes the recent progress of nanomaterials in tumor targeted therapy.
format Online
Article
Text
id pubmed-10405625
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104056252023-08-08 Research progress of nanomaterial drug delivery in tumor targeted therapy Zhang, Peng Ye, Guihua Xie, Guofeng Lv, Jie Zeng, Xianhai Jiang, Wei Front Bioeng Biotechnol Bioengineering and Biotechnology Cancer is one of the most lethal diseases in human society, and its incidence is gradually increasing. However, the current tumor treatment often meets the problem of poor efficacy and big side effects. The unique physical and chemical properties of nanomaterials can target the delivery of drugs to tumors, which can improve the therapeutic effect while reducing the damage of drugs to normal cells. This makes nanomaterials become a hot topic in the field of biomedicine. This review summarizes the recent progress of nanomaterials in tumor targeted therapy. Frontiers Media S.A. 2023-07-24 /pmc/articles/PMC10405625/ /pubmed/37555076 http://dx.doi.org/10.3389/fbioe.2023.1240529 Text en Copyright © 2023 Zhang, Ye, Xie, Lv, Zeng and Jiang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Zhang, Peng
Ye, Guihua
Xie, Guofeng
Lv, Jie
Zeng, Xianhai
Jiang, Wei
Research progress of nanomaterial drug delivery in tumor targeted therapy
title Research progress of nanomaterial drug delivery in tumor targeted therapy
title_full Research progress of nanomaterial drug delivery in tumor targeted therapy
title_fullStr Research progress of nanomaterial drug delivery in tumor targeted therapy
title_full_unstemmed Research progress of nanomaterial drug delivery in tumor targeted therapy
title_short Research progress of nanomaterial drug delivery in tumor targeted therapy
title_sort research progress of nanomaterial drug delivery in tumor targeted therapy
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405625/
https://www.ncbi.nlm.nih.gov/pubmed/37555076
http://dx.doi.org/10.3389/fbioe.2023.1240529
work_keys_str_mv AT zhangpeng researchprogressofnanomaterialdrugdeliveryintumortargetedtherapy
AT yeguihua researchprogressofnanomaterialdrugdeliveryintumortargetedtherapy
AT xieguofeng researchprogressofnanomaterialdrugdeliveryintumortargetedtherapy
AT lvjie researchprogressofnanomaterialdrugdeliveryintumortargetedtherapy
AT zengxianhai researchprogressofnanomaterialdrugdeliveryintumortargetedtherapy
AT jiangwei researchprogressofnanomaterialdrugdeliveryintumortargetedtherapy

Ejemplares similares